References
- Bousquet J, Jeffery P K, Busse W W, Johnson M, Vignola A M. Asthma-from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161: 1720–1745
- Busse W W, Lemanske R F, Jr. Asthma. N Engl J Med 2001; 344: 350–362
- Martinez F D. Development of wheezing disorders and asthma in preschool children. Pediatrics 2002; 109: 362–367
- Lukacs N W, Oliveira S HP, Hogaboam C M. Chemokines and asthma: redundancy of function or a coordinated effort?. J Clin Invest 1999; 104: 995–999
- Lederman M M, Penn-Nicholson A, Cho M, Mosier D. Biology of CCR5 and its role in HIV infection and treatment. JAMA 2006; 296: 815–826
- Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, Dayer J M. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391: 344–345
- Schliekelman P, Garner C, Slatkin M. Natural selection and resistance to HIV. Nature 2001; 411: 545–546
- Lucotte G, Mercier G. Distribution of the CCR5 gene 32-bp deletion in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 174–177
- Dean M, Carrington M, Winkler C, Huttley G A, Smith M W, Allikmets R, Goedert J J, Buchbinder S P, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996; 273: 1856–1862
- Dawson T C, Beck M A, Kuziel W A, Henderson F, Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 2000; 156: 1951–1959
- Carr D JJ, Ash J, Lane T E, Kuziel W A. Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. J Gen Virol 2006; 87: 489–499
- Thio C L, Astemborski J, Bashirova A, Mosbruger T, Greer S, Witt M D, Goedert J J, Hilgartner M, Majeske A, O'Brien S J, Thomas D L, Carrington M. Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence. J Virol 2007; 81: 441–445
- Sun X, Jones H P, Hodge L M, Simecka J W. Cytokine and chemokine transcription profile during Mycoplasma pulmonis infection in susceptible and resistant strains of mice: macrophage inflammatory protein 1β (CCL4) and monocyte chemoattractant protein 2 (CCL8) and accumulation of CCR5+ Th cells. Infect Immun 2006; 74: 5943–5954
- van Veen T, Nielsen J, Berkhof J, Barkhof F, Kamphorst W, Bö L, Ravid R, Verweij C L, Huitinga I, Polman C H, Uitdehaag B M. CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis. J Neuroimmunol 2007; 190: 157–164
- Bogunia-Kubik K, Duda D, Suchnicki K, Lange A. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Haematologica 2006; 91: 1628–1634
- Hall I P, Wheatley A, Christie G, McDougall C, Hubbard R, Helms P J. Association of CCR5 delta32 with reduced risk of asthma. Lancet 1999; 354: 1264–1265
- Srivastava P, Helms P J, Stewart D, Main M, Russell G. Association of CCR5Δ 32 with reduced risk of childhood but not adult asthma. Thorax 2003; 58: 222–226
- Mitchell T J, Walley A J, Pease J E. Delta 32 deletion of CCR5 gene and association with asthma or atopy. Lancet 2000; 356: 1491–1492
- Nagy A, Kozma G T, Bojszko A, Krikovszky D, Falus A, Szalai C. No association between asthma or allergy and the CCR5Δ 32 mutation. Arch Dis Child 2002; 86: 426
- Batra J, Sharma M, Chatterjee R, Sharma S, Mabalirajan U, Ghosh B. CCR5 Delta32 deletion and atopic asthma in India. Thorax 2005; 60: 85
- American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–244
- Beach J R, Young Avery A J, Stenton S C, Dennis J H, Walters E H, Hendrick D J. Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response. Thorax 1993; 48: 239–243
- Sterk P J, Fabbri L M, Quanjer P H, Cockcroft D W, O'Byrne P M, Anderson S D, Juniper E F, Malo J-L. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993; 6: 53–83
- American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912–930
- Salem A H, Batzer M A. Distribution of the HIV resistance CCR5-D32 allele among Egyptians and Syrians. Mutation Research 2007; 616: 175–180
- Souëf P N. Variations in genetic influences on the development of asthma throughout childhood, adolescence and early adult life. Curr Opin Allergy Clin Immunol 2006; 5: 317–322
- Prahalad S, Bohnsack J F, Jorde L B, Whiting A, Clifford B, Dunn D, Weiss R, Moroldo M, Thompson S D, Glass D N, Bamshad M J. Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis. Genes Immun 2006; 7: 468–475
- Kimpen J LL. Viral infections and childhood asthma. Am J Crit Care Med 2000; 162: 108–112
- Sutherland E R, Martin R J. Asthma and atypical bacterial infection. Chest 2007; 132: 1962–1966
- Ungvári I, Tölgyesi G, Semsei A, Nagy A, Radosits K, Keszei M, Kozma G, Falus A, Szalai C. CCR5Δ 32 mutation, Mycoplasma pneumoniae infection, and asthma. J Allergy Clin Immunol 2007; 119: 1545–1547